There are two dominant systems of accounting used by corporations around the world. In the U.S., companies use the generally accepted accounting principles, or GAAP, while international companies use ...

GAAP revenue of $19.1 million in Q2 2025 exceeded consensus by 49.6%, driven by recognition of partnership milestone payments. R&D expenses declined 28.4%, while SG&A rose 65.5%, both on a GAAP basis ...

GAAP revenue far exceeded expectations, reaching $160 million in Q2 2025, driven by a one-time $143 million GAAP catch-up related to program changes with Gilead. GAAP earnings per share reached ...

Dollars are in millions, except earnings per share. See “About Non-GAAP Financial Measures” below for more information regarding financial measures not prepared in accordance with Generally Accepted ...

Arcutis Biotherapeutics is a biopharmaceutical firm dedicated to creating and commercializing treatments for chronic skin conditions. Its primary product family, ZORYVE, features a range of topical ...

WELLSTAR, the Company's pure-play SaaS technology subsidiary, achieved revenue of $17.3 million in Q3-2025, an increase of 68% compared to $10.3 million in Q3-2024. WELLSTAR's growth was driven by ...

Traws Pharma develops experimental drugs aimed at preventing and treating respiratory viral infections, especially COVID-19 and influenza. Its business centers on moving two core antiviral candidates ...